Brought to you by:
Vascular surgery moves to assess trainees’ competence with EPAs
For surgeons, “EPA” means not the “Environmental Protection Agency” but “Entrustable Professional Activity”—and they’re going to change surgery training. A pilot rollout for vascular surgeons will begin in select centers in the fall with Vascular Surgery Board (VSB) implementation expected…
SVS Foundation announces 2023 student fellowship awards
The Society for Vascular Surgery (SVS) Foundation has announced the winners of the 2023 Student Research Fellowship Awards. The award is for undergraduate college and medical school students registered at universities in the United States and Canada. Its intent is…
SVS webinar discusses BEST-CLI and early impacts on practice
A recording of the inaugural “SVS Presents” virtual educational session, on the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) trial and its effect on vascular surgery, is now available. More than 150 people joined…
Interim data find ‘no evidence of benefit’ for carotid revascularization additional to optimized medical therapy
Interim results from the ECST-2 randomized controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with optimized medical therapy, will benefit from additional carotid revascularization via carotid endarterectomy (CEA) or carotid artery…
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism (PE), Ripal Gandhi, MD, Miami Cardiac & Vascular Institute & Miami Cancer Institute, Miami, elaborated on…
Urban residents have smaller risk of mortality from chronic limb-threatening ischemia
A new study using data from millions of patients hospitalized across the U.S. has determined whether population density and associated urban versus suburban versus rural environments predispose patients with peripheral vascular disease for chronic poor blood flow in their lower…
Advance: Navigating the policy and political processes on Capitol Hill
The underlying processes associated with advocacy—whether legislative, regulatory or political—are arduous and complex. As a result, measures of “success” are often characterized by progress within the process, or in other words, to advance a given initiative even if additional work…
We can honor the past without living in it
Malachi Sheahan III, MD, peels back the layers on why a decision by the Southern Association for Vascular Surgery (SAVS) to replace its signature emblem is the right one. Imagine you are considering moving to a country where you will…
Insights from largest chronic limb-threatening ischaemia study to inform quality of care improvements
Data from a cohort of one million patients with chronic limb-threatening ischaemia (CLTI) were recently presented as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions (18–20 May, Phoenix, USA). Using data from Medicare, the…
JETi registry provides “remarkable results” for peripheral thrombectomy system
Presenting “remarkable results” from the JETi registry—a prospective, multicenter, observational study which collected real-world data on the safety, performance and clinical benefits of the JETi peripheral thrombectomy system—speaker Mahmood K. Razavi, MD, relayed the positive outcomes seen with the “powerful”…